Journals / Türkiye Parazitoloji Dergisi / 2018 / Cilt: 42 - Sayı: 3

A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone–Proguanil

Atovaquone-Proguanil ile Tedavi Edilen Rekrudesens Plasmodium falciparum Sıtması: Olgu Sunumu

Pages
233–236
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the present study, we described a patient diagnosed with falciparum malaria and treated with atovaquone–proguanil who had a history of traveling to Uganda.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malaria is a potentially life-threatening disease caused by infection with the Plasmodium protozoa transmitted by an infective female Anopheles mosquito.
📊
Key Findings & Data:Despite successful control programs in many countries, malaria remains to be a major disease burden worldwide, with approximately 584,000 deaths annually.
💡
Conclusion & Impact:In the present study, we described a patient diagnosed with falciparum malaria and treated with atovaquone–proguanil who had a history of traveling to Uganda.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Malaria is a potentially life-threatening disease caused by infection with the Plasmodium protozoa transmitted by an infective female Anopheles mosquito. Despite successful control programs in many countries, malaria remains to be a major disease burden worldwide, with approximately 584,000 deaths annually. The incidence of the disease and responsible species may differ due to increased human movements between countries. Plasmodium falciparum infection carries a poor prognosis with a high mortality if untreated, but it has an excellent prognosis if diagnosed early and treated appropriately. In the present study, we described a patient diagnosed with falciparum malaria and treated with atovaquone–proguanil who had a history of traveling to Uganda.

Özet

Sıtma, enfekte dişi anofel cinsi sivrisenekler tarafından taşınan Plasmodium cinsi protozooların neden olduğu hayatı tehdit edici olabilenbir parazit enfeksiyonudur. Birçok ülkede başarılı sıtma kontrol programlarına rağmen, yılda yaklaşık 580.000 ölüme neden olan önemli birküresel hastalık yükü olmaya devam etmektedir. Ülkeler arasında artan insan hareketliliği nedeniyle hastalık insidansı ve sorumlu olan türlerdeğişkenlik gösterebilir. Tedavi edilmediği takdirde Plasmodium falciparum prognozu kötüdür, fakat erken tanı ve uygun tedavi ile prognozuçok iyidir. Bu yazıda atovaquone- preguanil ile tedavi edilen Uganda kaynaklı bir falciparum sıtması olgusu sunduk.

🔖

Cite This Article

AYDIN, Z. G. G., BAYHAN, G. İ., KAMAN, A., TEKE, T. A., AKKAYA, B., TANIR, G. (2022). A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone–Proguanil. Türkiye Parazitoloji Dergisi, Cilt: 42 - Sayı: 3, 233–236. https://ajindex.com/articles/630082

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Gutman J, Arguin PM. Plasmodium Species (Malaria). Long SS, Prober CG, Fischer M (ed) Principles and Practice of Pediatric Infectious Diseases. 5. ed, Philadelphia: Elsevier, 2018. p. 1342- 50. Available from: https://www.clinicalkey.com/#!/content/book/ 3-s2.0-B9780323401814002711. [Accessed: 1 December, 2017] 2. Özbilgin A, Çavuş İ, Yıldırım A, Gündüz C. The first monkey malaria in Turkey: a case of Plasmodium knowlesi. Mikrobiyol Bul 2016
  2. [CrossRef] 3. Tamer GS, Yılmaz M, Akçer B. Evaluation of Malaria Cases that Were Detected in Kocaeli Province During 2008 Through 2013. Turkiye Parazitol Derg 2015
  3. [CrossRef] 4. Erdil Z, Kurt C, Kalaycı HÖ, Gözlükaya Ö, Tayar C. Two Imported Malaria Cases Caused by Plasmodium falciparum in A Week. Turkiye Parazitol Derg 2016
  4. [CrossRef] 5. Altun HU, Gül YK, Vudalı E, Hatipoğlu ÇA, Bulut C, Yağci S, et al. Plasmodium falciparum malaria case originating from Uganda. Turkiye Parazitol Derg 2013
  5. [CrossRef] 6. Arslan F, Mert A, Batirel A, Inan A, Balkan II, Nazlican O, et al. Imported Plasmodium falciparum malaria in Istanbul, Turkey: risk factors for severe course and mortality. Trop Doct 2013
  6. [CrossRef] 7. Ülçay A, Karaahmetoğlu G, Turhan V, Erdem H, Acar A, Öncül O, et al. The management of therapeutic failure in a falciparum malaria patient under oral arthemether-lumefantrine therapy. Turkiye Parazitol Derg 2014
  7. [CrossRef] 8. World Health Organization (2014). World malaria report 2014. Available from: http://www.who.int/malaria/publications/world_ malaria_report_20 14/report/en/. [Accessed 12 November, 2017]. [CrossRef] 9. World Health Organization (2017). World Malaria Report 2017. Available: http://www.who.int/malaria/publications/world_malaria_report/ en/. [Accessed 12 December, 2017]. [CrossRef] 10. Turkiye Cumhuriyeti Sağlık Bakanlığı, Sağlık İstatistikleri Yıllığı 2015. Available from: http://www.saglikistatistikleri.gov.tr/dosyalar/ SIY_2015.pdf. [Erişim 12 Aralık 2017]. 11. Uyar Y, İnanç T, Şahin S, Kuk S, Yazar S. The Epidemiology of Malaria in Kayseri Between 2001 and 2013. Turkiye Parazitol Derg 2015
  8. [CrossRef] 12. Fairhurst RM, Wellems TE. Malaria. (Plasmodium Species). Bennett JE, Dolin R, Blaser MJ (ed). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Updated Edition. 8. ed, Philadelphia: Elsevier Inc, 2015: 3070-90. 13. Ulusal Mikrobiyoloji Standartları (UMS) Cilt 3. Mikrobiyolojik tanımlam